These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 14300296)

  • 61. Live measles vaccine from a further attenuated strain SEVAC.
    Mares I; Drevo M; Adam E; Kubátová M; Casny J
    Prog Immunobiol Stand; 1967; 3():188-91. PubMed ID: 5379938
    [No Abstract]   [Full Text] [Related]  

  • 62. Clinical and immunologic observations on two lines of attenuated measles vaccine virus upon passage in chick embryo cell culture.
    Chun H; T'eh-chang H; Kuo-hua T; Shou-teh C; Wen-huan W; Chi-ming C; Yu-fen K; Chü-yeh Y; Lan H
    Chin Med J (Engl); 1975 Jul; 1(4):283-6. PubMed ID: 810334
    [No Abstract]   [Full Text] [Related]  

  • 63. The status of measles after five years of mass vaccination in the USSR.
    Burgasov PN; Andzaparidze OG; Popov VF
    Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Studies on the combined use of attenuated and live vaccines for measles. 1. Evaluation of vaccination with live vaccine after administration of the attenuated vaccine once or twice].
    Seki T
    Nihon Shonika Gakkai Zasshi; 1966 Dec; 70(12):1340-9. PubMed ID: 6010153
    [No Abstract]   [Full Text] [Related]  

  • 65. A FOLLOW-UP STUDY OF IMMUNITY IN CHILDREN VACCINATED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
    HALONEN P; FORSSELL P; BACKMAN A
    Arch Gesamte Virusforsch; 1965; 16():268-72. PubMed ID: 14322876
    [No Abstract]   [Full Text] [Related]  

  • 66. Measles virus.
    Naim HY
    Hum Vaccin Immunother; 2015; 11(1):21-6. PubMed ID: 25483511
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells.
    Cepleanu M; Cajal N; Cernescu C; Sorodoc Y; Aderca I; Tigăeru N; Suciu D; Manu S; Ferra A; Biberimoroianu S; Dobrescu A; Lucian M
    Rev Roum Virol (1972); 1973; 10(1):8-17. PubMed ID: 4709858
    [No Abstract]   [Full Text] [Related]  

  • 68. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.
    FELDMAN HA
    Arch Gesamte Virusforsch; 1965; 16():329-30. PubMed ID: 14322887
    [No Abstract]   [Full Text] [Related]  

  • 69. [Time of the appearance of immunity to measles after the administration of a live measles vaccine].
    Revenok ND
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():355-60. PubMed ID: 5860953
    [No Abstract]   [Full Text] [Related]  

  • 70. Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.
    Rennick LJ; de Vries RD; Carsillo TJ; Lemon K; van Amerongen G; Ludlow M; Nguyen DT; Yüksel S; Verburgh RJ; Haddock P; McQuaid S; Duprex WP; de Swart RL
    J Virol; 2015 Feb; 89(4):2192-200. PubMed ID: 25473055
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CLINICAL TRIAL OF FURTHER ATTENUATED MEASLES VACCINE.
    BENSON PF; BUTLER NR
    Guys Hosp Rep; 1964; 113():349-53. PubMed ID: 14225140
    [No Abstract]   [Full Text] [Related]  

  • 72. Investigation and appplication of the USSR AMS live measles vaccine from the ESC strain for mass vaccination against measles.
    Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):1-18. PubMed ID: 4985647
    [No Abstract]   [Full Text] [Related]  

  • 73. MEASLES VACCINE: RESULTS OF STUDIES WITH BOTH KILLED AND LIVE VIRUS VACCINE.
    RILEY HD
    Memphis Mid South Med J; 1964 Jul; 39():241-51. PubMed ID: 14178142
    [No Abstract]   [Full Text] [Related]  

  • 74. [Dynamics of the serologic response of children vaccinated with live AMN USSR measles vaccine prepared from the ESzCz strain].
    Sinjak KM; Czumakow MP; Rodin WI; Czudnaja LM; Sziechtier AB; Winograd IA; Urin AI; Glinskaja LA; Szwiec LT; Knjaziewa II; Niemiec ZA
    Przegl Epidemiol; 1970; 24(1):15-20. PubMed ID: 5431385
    [No Abstract]   [Full Text] [Related]  

  • 75. Vaccination against measles: a neverending story.
    Stittelaar KJ; de Swart RL; Osterhaus AD
    Expert Rev Vaccines; 2002 Aug; 1(2):151-9. PubMed ID: 12901554
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [CHANGES IN SENSITIVITY TO TUBERCULIN CAUSED BY THE ENDERS VACCINE OF ATTENUATED LIVE MEASLES VIRUS].
    BUSTAMANTE S
    Rev Chil Pediatr; 1964 May; 35():447-8. PubMed ID: 14219297
    [No Abstract]   [Full Text] [Related]  

  • 77. [New methods on the measles prophylaxis (author's transl)].
    de Blasi R; Fazio-Gentile G
    Ann Sclavo; 1979; 21(2):113-59. PubMed ID: 485597
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Data for the evaluation of the epidemiological effectiveness of a live measles vaccine prepared from the Leningrad-4 strain].
    Nikitin MIa; Kozlova NA; Kulikova VA; Malafeeva LK; Petrova TN
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():309-20. PubMed ID: 5893106
    [No Abstract]   [Full Text] [Related]  

  • 79. [Serologic indices of measles immunity in children exposed to measles].
    Tikhonova NT; Khrometskaia TM; Ignat'eva GV; Gerasimova AG; Livanova LV
    Vopr Virusol; 1974; 19(0):357-63. PubMed ID: 4837951
    [No Abstract]   [Full Text] [Related]  

  • 80. [Data for the study of reactogenic and epidemiological effectiveness of a live measles vaccine prepared from the Leningrad-16 strain].
    Nikitin MIa; Kozlova NA; Kulikova VA; Petrova TN
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():321-9. PubMed ID: 5860951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.